import { db } from "@workspace/db";
import { blogPostsTable } from "@workspace/db";

const posts = [
  {
    title: "BPC-157: Mechanisms of Tissue Repair in Preclinical Research",
    slug: "bpc-157-tissue-repair-mechanisms",
    excerpt: "Body Protection Compound-157 has emerged as one of the most studied peptides in regenerative research. We examine its proposed mechanisms across tendon, muscle, and gastrointestinal models.",
    content: `## Introduction

Body Protection Compound-157 (BPC-157) is a synthetic pentadecapeptide derived from the gastric juice protein BPC. With the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, it has been the subject of extensive preclinical investigation across a wide range of tissue repair models.

## Proposed Mechanisms

### Angiogenesis Promotion

Multiple in vitro and in vivo studies have reported that BPC-157 upregulates VEGF (vascular endothelial growth factor) expression, promoting the formation of new blood vessels at injury sites. This neovascularisation is thought to accelerate nutrient delivery to healing tissue.

### Nitric Oxide Pathway Modulation

BPC-157 has been shown in rodent models to influence the nitric oxide (NO) system, modulating both eNOS and nNOS activity. This may contribute to its observed cytoprotective effects in gastric mucosa.

### Tendon-to-Bone Healing

Research published in the *Journal of Orthopaedic Research* demonstrated accelerated tendon-to-bone healing in a rat Achilles tendon transection model, with histological evidence of improved collagen organisation and fibroblast proliferation.

### Gastrointestinal Protection

Perhaps the most consistently replicated finding is BPC-157's protective effect on gastric mucosa against NSAID-induced lesions, alcohol, and corrosion. The mechanism appears to involve both PGE2 modulation and direct cell proliferation signalling.

## Research Considerations

BPC-157 is approved exclusively for in vitro research purposes. All data referenced here derives from animal and cell culture studies. Human pharmacokinetics, safety profiles, and efficacy have not been established in clinical trials.

## Conclusion

BPC-157 remains one of the most mechanistically versatile peptides in the preclinical literature. Its apparent activity across diverse tissue types makes it a compelling subject for continued investigation, though researchers should carefully distinguish between replicated and single-study findings.`,
    author: "OmniQure Research Team",
    tags: ["BPC-157", "Tissue Repair", "Angiogenesis", "Gastric Protection"],
    status: "published" as const,
    publishedAt: new Date("2026-06-01T09:00:00Z"),
    seoTitle: "BPC-157 Tissue Repair Mechanisms | OmniQure Research",
    seoDescription: "An in-depth look at the proposed mechanisms of BPC-157 in preclinical tissue repair research, covering angiogenesis, NO pathways, and gastrointestinal models.",
  },
  {
    title: "TB-500 and Thymosin Beta-4: What the Research Actually Shows",
    slug: "tb-500-thymosin-beta-4-research-review",
    excerpt: "TB-500 is a synthetic analogue of the naturally occurring protein Thymosin Beta-4. This review examines the peer-reviewed literature on its role in actin sequestration, wound healing, and cardiac models.",
    content: `## Background

Thymosin Beta-4 (Tβ4) is a ubiquitous 43-amino acid protein found in virtually all mammalian cells. Its primary established role is as the main intracellular G-actin sequestering molecule, regulating the pool of monomeric actin available for polymerisation. TB-500 refers to a synthetic fragment corresponding to amino acids 17–23 of Tβ4 (Ac-LKKTETQ), which is proposed to retain key bioactive properties.

## Actin Dynamics and Cell Migration

The sequestration of G-actin by Tβ4 is critical for lamellipodia formation and directed cell migration. In wound healing models, this translates to enhanced keratinocyte and endothelial cell migration toward the wound edge, a prerequisite for re-epithelialisation.

## Cardiac Research

A series of studies from the Bhatt laboratory demonstrated that Tβ4 can activate cardiac progenitor cells in mouse infarction models, promoting cardiomyocyte survival and modest regeneration. This has generated significant interest in the peptide's potential in myocardial research, though translation to clinical contexts remains speculative.

## Angiogenesis

Like BPC-157, Tβ4/TB-500 has been associated with upregulation of VEGF and promotion of endothelial tube formation in vitro. However, the two peptides appear to operate via distinct upstream mechanisms, making combination studies a potentially fruitful area of inquiry.

## Anti-Inflammatory Properties

Several papers report that Tβ4 downregulates NF-κB signalling and reduces pro-inflammatory cytokine expression (IL-1β, TNF-α) in macrophage models. This immunomodulatory role may be relevant to chronic wound healing scenarios.

## Research Limitations

Most TB-500 research utilises recombinant full-length Tβ4 rather than the synthetic fragment marketed as TB-500. Researchers should be cautious when extrapolating results between these molecules. All studies referenced are preclinical.

## Summary

TB-500/Thymosin Beta-4 represents a well-mechanistically grounded research peptide with consistent activity across wound healing, cardiac, and inflammatory models. Its actin-sequestering mechanism distinguishes it from growth factor-based peptides and offers a distinct research angle.`,
    author: "OmniQure Research Team",
    tags: ["TB-500", "Thymosin Beta-4", "Wound Healing", "Cardiac Research"],
    status: "published" as const,
    publishedAt: new Date("2026-06-05T09:00:00Z"),
    seoTitle: "TB-500 & Thymosin Beta-4 Research Review | OmniQure",
    seoDescription: "A critical review of the peer-reviewed literature on TB-500 and Thymosin Beta-4, covering actin dynamics, wound healing, cardiac regeneration, and anti-inflammatory mechanisms.",
  },
  {
    title: "GHK-Cu: Copper Peptide Science and Skin Biology Research",
    slug: "ghk-cu-copper-peptide-skin-biology",
    excerpt: "GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) has accumulated an impressive body of research spanning wound healing, gene expression, and anti-ageing biology. We review the current evidence base.",
    content: `## What is GHK-Cu?

GHK-Cu is a naturally occurring tripeptide-copper complex first isolated from human plasma by Dr Loren Pickart in 1973. The molecule consists of glycyl-L-histidyl-L-lysine coordinated with a Cu²⁺ ion. Plasma concentrations of GHK decline markedly with age — from approximately 200 ng/mL at age 20 to around 80 ng/mL by age 60 — a pattern that has driven research interest in its role in systemic repair signalling.

## Gene Expression Modulation

Perhaps the most remarkable finding in recent GHK-Cu research is its broad effect on gene expression. Pickart and colleagues demonstrated using microarray analysis that GHK-Cu modulates over 4,000 human genes, upregulating many involved in tissue remodelling, anti-inflammatory signalling, and DNA repair, while downregulating genes associated with cancer progression and inflammation.

## Wound Healing and Collagen Synthesis

The established body of work on GHK-Cu in wound healing models is substantial:

- **Collagen synthesis**: Multiple studies confirm upregulation of collagen types I, III, and VI in fibroblast cultures
- **Glycosaminoglycan synthesis**: Increased hyaluronic acid and dermatan sulphate production
- **Wound contraction**: Accelerated wound closure in rodent excisional models
- **Angiogenesis**: VEGF upregulation and endothelial tube formation in vitro

## Anti-Ageing and Extracellular Matrix Research

GHK-Cu has demonstrated consistent activity in reducing the expression of matrix metalloproteinases (MMPs) responsible for collagen degradation, while simultaneously increasing expression of tissue inhibitors of metalloproteinases (TIMPs). This dual action on ECM turnover is a key area of cosmeceutical and geroscience research.

## Neurological Research

Emerging research suggests GHK-Cu may have neuroprotective properties, including upregulation of BDNF expression and modulation of oxidative stress pathways in neuronal models. This remains an early-stage area.

## HPLC Stability Considerations

Researchers working with GHK-Cu should be aware that the peptide-copper complex can be sensitive to pH and temperature. Reconstitution in slightly acidic aqueous solution (pH 5–6) and storage at -20°C is generally recommended for short-term stability.

## Conclusion

GHK-Cu stands apart from many research peptides by virtue of its well-characterised natural occurrence, its decades-long research history, and its unusually broad gene regulatory activity. It continues to be one of the most scientifically substantiated peptides in the skin biology and geroscience literature.`,
    author: "OmniQure Research Team",
    tags: ["GHK-Cu", "Copper Peptide", "Collagen", "Skin Biology", "Gene Expression"],
    status: "published" as const,
    publishedAt: new Date("2026-06-09T09:00:00Z"),
    seoTitle: "GHK-Cu Copper Peptide Science | OmniQure Research Blog",
    seoDescription: "A comprehensive review of GHK-Cu research, covering gene expression modulation, collagen synthesis, wound healing, and emerging neurological findings.",
  },
  {
    title: "Understanding Peptide Reconstitution: A Researcher's Guide",
    slug: "peptide-reconstitution-guide",
    excerpt: "Proper reconstitution is critical to research reproducibility. This guide covers solvent selection, concentration calculations, storage conditions, and common mistakes that compromise data quality.",
    content: `## Why Reconstitution Matters

Lyophilised peptides are supplied in dry powder form for stability during shipping and storage. The process of reconstituting them into solution is the first and often most consequential step in any research protocol. Errors at this stage — wrong solvent, incorrect concentration, inadequate mixing, or improper storage — can invalidate experiments before they begin.

## Solvent Selection

The appropriate solvent depends on the peptide's amino acid composition and sequence:

### Aqueous Peptides
Peptides with predominantly hydrophilic residues (Asp, Glu, Arg, Lys, His) typically dissolve well in:
- Sterile water for injection (WFI)
- Phosphate-buffered saline (PBS)
- 0.9% sodium chloride solution

### Hydrophobic Peptides
Peptides with significant hydrophobic content (Trp, Phe, Leu, Val) may require:
- A small volume of glacial acetic acid (5–10%) followed by dilution with water
- DMSO as a co-solvent (typically ≤10% final concentration)
- Acetonitrile for initial dissolution prior to aqueous dilution

### BPC-157 Specifically
BPC-157 dissolves readily in sterile water or acidic aqueous solution. Most researchers use sterile 0.9% NaCl or WFI. Avoid strongly alkaline conditions.

### GHK-Cu Specifically
As a copper complex, GHK-Cu dissolves best in slightly acidic aqueous solution (pH 5–6). Phosphate buffers at neutral pH can cause precipitation.

## Concentration Calculations

The reconstitution calculator on our site automates this, but the underlying formula is:

**Volume (mL) = Mass (mg) / [Concentration (mg/mL)]**

Or in molar terms:

**Volume (mL) = [Mass (mg) / Molecular Weight (g/mol)] × 1000 / [Target concentration (mM)]**

### Example: BPC-157
- MW: 1419.5 g/mol
- Vial: 5 mg
- Target: 1 mg/mL (703 µM)
- Add: 5 mL sterile water

## Mixing Technique

1. **Do not vortex** — mechanical shearing can denature peptides
2. Gently swirl or roll the vial
3. If dissolving slowly, allow to sit at room temperature for 5–10 minutes
4. Check for complete dissolution before use — visual clarity is necessary but not sufficient (some precipitates are too fine to see)

## Aliquoting and Storage

- Prepare aliquots immediately after reconstitution to minimise freeze-thaw cycles
- Suggested aliquot volumes: enough for one experimental run
- Short-term (≤1 week): 4°C, sealed
- Long-term: -20°C or -80°C in low-binding tubes
- Avoid repeated freeze-thaw (limit to ≤3 cycles for most peptides)

## Common Mistakes

| Mistake | Consequence |
|---|---|
| Reconstituting in the wrong solvent | Precipitation, inactivity |
| Using tap water | Microbial contamination, ion interference |
| Vigorous vortexing | Peptide denaturation |
| Storing at 4°C long-term | Degradation, bacterial growth |
| Multiple freeze-thaw cycles | Progressive activity loss |

## Quality Checks

Before using reconstituted peptide in experiments, verify:
- Visual clarity (absence of visible precipitate)
- Correct volume
- Absence of colour change (most peptides should be colourless to faintly yellow)
- pH if relevant to your model system

## Conclusion

Reproducible peptide research starts with reproducible reconstitution. Standardising your solvent, concentration, mixing, and storage protocols — and documenting each step — is foundational to generating reliable data.`,
    author: "OmniQure Research Team",
    tags: ["Reconstitution", "Laboratory Technique", "Research Protocol", "Peptide Storage"],
    status: "published" as const,
    publishedAt: new Date("2026-06-12T09:00:00Z"),
    seoTitle: "Peptide Reconstitution Guide for Researchers | OmniQure",
    seoDescription: "A complete guide to peptide reconstitution covering solvent selection, concentration calculations, storage, and common mistakes that affect research quality.",
  },
  {
    title: "Semaglutide and GLP-1 Receptor Agonists: The Metabolic Research Landscape",
    slug: "semaglutide-glp1-metabolic-research",
    excerpt: "GLP-1 receptor agonists have reshaped metabolic research. This article surveys the mechanistic literature on semaglutide, focusing on pancreatic beta-cell function, appetite regulation, and cardiovascular effects.",
    content: `## The GLP-1 Receptor Agonist Class

Glucagon-like peptide-1 (GLP-1) is a 30-amino-acid incretin hormone secreted by L-cells of the intestinal mucosa in response to nutrient ingestion. Its principal physiological actions include:

- Glucose-dependent insulin secretion from pancreatic beta cells
- Suppression of glucagon secretion
- Gastric emptying delay
- Central appetite regulation via hypothalamic and brainstem pathways

Semaglutide is a GLP-1 analogue modified to extend its half-life from approximately 2 minutes (native GLP-1) to approximately 7 days, achieved through a C-18 fatty diacid chain attachment and two amino acid substitutions.

## Pancreatic Effects

### Beta-Cell Function
In rodent models, semaglutide and related GLP-1 agonists have been shown to:
- Stimulate insulin gene transcription
- Promote beta-cell proliferation
- Inhibit beta-cell apoptosis under glucotoxic and lipotoxic conditions

These effects operate through cAMP/PKA and PI3K/Akt signalling pathways downstream of GLP-1R activation.

### Alpha-Cell Suppression
Glucagon suppression under hyperglycaemic conditions is a well-replicated effect, reducing hepatic glucose output and contributing to improved glycaemic control models.

## Central Nervous System Effects

GLP-1 receptors are expressed throughout the brain, including in the arcuate nucleus, nucleus of the solitary tract, and area postrema. Semaglutide has demonstrated:

- Reduction in caloric intake in rodent free-feeding models
- Modulation of dopaminergic reward circuits (reduced food reward motivation)
- Possible neuroprotective effects in models of Parkinson's and Alzheimer's disease (an emerging area of active investigation)

## Cardiovascular Research

The SUSTAIN and PIONEER clinical trial programmes demonstrated cardiovascular risk reduction with semaglutide in type 2 diabetes populations. The proposed mechanisms from mechanistic studies include:

- Direct endothelial GLP-1R activation reducing oxidative stress
- Anti-inflammatory effects on atherosclerotic plaque
- Blood pressure reduction via natriuresis
- Improvements in lipid profiles

## Research Considerations

Semaglutide is available for in vitro and in vivo research purposes. Researchers should note that the subcutaneous formulation (Ozempic) and oral formulation (Rybelsus) have distinct pharmacokinetic profiles, and research-grade semaglutide may differ from pharmaceutical-grade material in formulation.

## Emerging Research Directions

- **Combination with tirzepatide-type dual agonism**: GLP-1/GIP dual receptor agonism represents a next-generation approach
- **Neurodegeneration models**: Multiple groups are investigating GLP-1R agonism in Parkinson's and Alzheimer's models
- **NASH/MASH**: Hepatic steatosis resolution in non-alcoholic steatohepatitis models
- **Muscle preservation**: The question of lean mass preservation during GLP-1-driven weight loss is an active research area

## Conclusion

Semaglutide and the GLP-1 receptor agonist class represent one of the most fertile areas of contemporary metabolic and cardiovascular research. The mechanistic literature is extensive and continues to expand into non-metabolic disease areas.`,
    author: "OmniQure Research Team",
    tags: ["Semaglutide", "GLP-1", "Metabolic Research", "Cardiovascular", "Diabetes"],
    status: "published" as const,
    publishedAt: new Date("2026-06-15T09:00:00Z"),
    seoTitle: "Semaglutide & GLP-1 Metabolic Research Overview | OmniQure",
    seoDescription: "Survey of the mechanistic research on semaglutide and GLP-1 receptor agonists, covering pancreatic function, appetite regulation, and cardiovascular effects.",
  },
  {
    title: "Epithalon: Telomere Biology and the Search for Longevity Peptides",
    slug: "epithalon-telomere-biology-longevity",
    excerpt: "Epithalon (Epitalon) is a tetrapeptide studied for its proposed effects on telomerase activity and pineal function. We examine the research evidence and contextualise it within broader longevity biology.",
    content: `## Background

Epithalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide analogue of Epithalamin, a natural polypeptide isolated from bovine pineal gland extracts. The compound was developed by Vladimir Khavinson and colleagues at the St Petersburg Institute of Bioregulation and Gerontology, where it has been the subject of study for over four decades.

## Telomere Research

The most widely cited claimed mechanism of Epithalon is activation of telomerase, the enzyme responsible for maintaining telomere length at chromosomal ends. Telomere attrition is associated with cellular senescence and is widely considered a biomarker of biological ageing.

### Key Studies
A study by Khavinson et al. in *Bulletin of Experimental Biology and Medicine* reported that Epithalon stimulated telomerase activity in human fetal fibroblasts and prolonged their replicative lifespan. Additional cell culture studies reported elongation of telomeres in treated cells.

### Critical Context
It is important to note that:
- Most Epithalon research originates from a single research group
- Independent replication by other laboratories is limited
- Cell culture findings do not necessarily translate to in vivo or clinical contexts
- Telomerase activation in somatic cells carries theoretical oncogenic risk at high levels

## Pineal Gland and Melatonin Research

Epithalon was originally investigated as a peptide bioregulator with activity in the hypothalamic-pineal axis. Animal studies reported:
- Normalisation of circadian melatonin production in aged rats
- Restoration of gonadotropin secretion patterns
- Life extension in multiple rodent and invertebrate models (up to 25% in some studies)

## Antioxidant Properties

Several studies report antioxidant effects, including reduction of lipid peroxidation markers and upregulation of antioxidant enzymes (SOD, catalase) in aged animal models.

## Regulatory and Research Status

Epithalon is a research peptide with no approved medical applications in any jurisdiction. Researchers interested in telomere biology, cellular senescence, or circadian regulation may find it a useful tool compound, but should approach the existing literature with appropriate critical evaluation given the limited independent replication.

## Broader Longevity Peptide Research

Epithalon is part of a growing area of research into short peptide bioregulators. The Khavinson group's broader Cytomax and Cytogen series represents a systematic attempt to develop organ-specific peptide regulators, though this work remains largely outside mainstream Western geroscience.

## Conclusion

Epithalon occupies an interesting niche in longevity research — mechanistically plausible, with a substantial body of primary research, but lacking the independent replication and rigorous study design that would place it alongside better-validated geroscience compounds. It remains a legitimate research subject, particularly for groups interested in telomere biology and peptide bioregulators.`,
    author: "OmniQure Research Team",
    tags: ["Epithalon", "Telomere", "Longevity", "Pineal Gland", "Anti-Ageing"],
    status: "published" as const,
    publishedAt: new Date("2026-06-18T09:00:00Z"),
    seoTitle: "Epithalon, Telomere Biology & Longevity Research | OmniQure",
    seoDescription: "An evidence-based review of Epithalon research, covering telomerase activation, pineal function, life extension studies, and critical evaluation of the evidence base.",
  },
  {
    title: "CJC-1295 and Ipamorelin: Growth Hormone Secretagogue Research",
    slug: "cjc-1295-ipamorelin-ghrh-ghrp-research",
    excerpt: "CJC-1295 and Ipamorelin act through complementary mechanisms to stimulate growth hormone release. This article reviews the pharmacology, research findings, and combination rationale for these two secretagogues.",
    content: `## The Growth Hormone Secretagogue Concept

Growth hormone (GH) secretion is regulated by two principal hypothalamic signals: Growth Hormone-Releasing Hormone (GHRH), which stimulates GH release, and somatostatin, which inhibits it. Ghrelin and its synthetic mimetics (GHRPs) provide an additional, complementary stimulatory pathway via the GHSR-1a receptor.

CJC-1295 and Ipamorelin exploit these two distinct mechanisms, making them a frequently studied combination in GH secretagogue research.

## CJC-1295: GHRH Analogue

CJC-1295 is a synthetic GHRH analogue with modifications at positions 2, 8, 15, and 27 to confer resistance to dipeptidyl peptidase-IV (DPP-IV) degradation. Two variants are commonly available:

### CJC-1295 with DAC (Drug Affinity Complex)
The DAC modification causes covalent binding to albumin via maleimide chemistry, extending the half-life from minutes to approximately 6–8 days. This produces sustained, non-pulsatile GHRH stimulation.

### CJC-1295 without DAC (Modified GRF 1-29)
Without DAC, the half-life is approximately 30 minutes, producing a more physiological pulsatile profile. This is often the preferred form for research seeking to maintain natural GH pulsatility.

### Published Research
A phase II clinical trial (Teichman et al., *JCEM*, 2006) demonstrated dose-dependent increases in GH and IGF-1 levels over 28 days with CJC-1295 with DAC, without significant adverse effects, providing important human pharmacological data.

## Ipamorelin: Selective GHRP

Ipamorelin is a pentapeptide GH secretagogue (His-D-2-MeAla-Trp-D-Phe-Lys-NH2) developed to be highly selective for the GHSR-1a receptor. Unlike first-generation GHRPs such as GHRP-2 and GHRP-6, Ipamorelin demonstrates minimal off-target effects:

- Negligible cortisol stimulation (unlike GHRP-2)
- Negligible prolactin stimulation
- No significant appetite stimulation (unlike GHRP-6)
- Clean GH pulse with minimal IGF-1 independent effects

### Research Findings
Animal studies have demonstrated that Ipamorelin reliably produces GH pulses with a 3–5 fold increase over baseline in rodent models. Its selectivity profile makes it a useful research tool for isolating GHSR-1a-mediated effects.

## Combination Rationale

The rationale for combining CJC-1295 and Ipamorelin is mechanistic synergy:

- CJC-1295 stimulates somatotrophs via GHRH receptor (Gsα/cAMP/PKA pathway)
- Ipamorelin stimulates via GHSR-1a (Gq/PKC pathway, also Gsα)
- Together they act on complementary second messenger systems
- Animal studies demonstrate that combination produces greater GH release than either alone

## Research Considerations

Studies examining these peptides focus on GH and IGF-1 as primary endpoints. Researchers should note that the physiological consequences of sustained IGF-1 elevation are distinct from those of pulsatile GH secretion, and experimental design should account for which endpoint is relevant to the research question.

## Conclusion

CJC-1295 and Ipamorelin represent well-characterised growth hormone secretagogues with complementary mechanisms, a clear pharmacological rationale for combination use, and an accessible research literature. Their selectivity profiles — particularly Ipamorelin's minimal off-target activity — make them valuable tools in GH axis research.`,
    author: "OmniQure Research Team",
    tags: ["CJC-1295", "Ipamorelin", "Growth Hormone", "GHRH", "GHRP", "Secretagogue"],
    status: "published" as const,
    publishedAt: new Date("2026-06-22T09:00:00Z"),
    seoTitle: "CJC-1295 & Ipamorelin GH Secretagogue Research | OmniQure",
    seoDescription: "Pharmacology and research findings for CJC-1295 and Ipamorelin, covering GHRH and GHRP mechanisms, combination rationale, and key published studies.",
  },
  {
    title: "HPLC Purity Testing: What the Data Actually Tells You",
    slug: "hplc-purity-testing-explained",
    excerpt: "High-performance liquid chromatography is the gold standard for peptide purity verification. This article explains what HPLC data means, how to read a chromatogram, and what limitations researchers should understand.",
    content: `## Why Purity Testing Matters

Research reproducibility depends critically on compound identity and purity. A peptide preparation that is 85% pure introduces up to 15% unknown material into every experiment — material that may itself be biologically active, toxic, or simply confounding. Understanding what purity data means — and what it cannot tell you — is an essential research skill.

## What is HPLC?

High-Performance Liquid Chromatography (HPLC) separates compounds based on their differential affinity for a stationary phase (column) and mobile phase (solvent system). For peptide analysis, reverse-phase HPLC (RP-HPLC) is standard:

- **Stationary phase**: C18 or C8 modified silica (hydrophobic)
- **Mobile phase**: Gradient of water/acetonitrile with 0.1% TFA or formic acid
- **Detection**: UV absorbance, typically at 214 nm (amide bond absorption)

Compounds elute from the column based on their hydrophobicity. The detector records a **chromatogram**: a plot of UV absorbance (y-axis) versus time (x-axis). Each peak represents a component of the mixture.

## Reading a Chromatogram

### The Main Peak
For a high-purity peptide, you should see one dominant, symmetrical peak. The **area percentage** of this peak (relative to total peak area in the chromatogram) gives you the purity figure.

### Retention Time
The time at which your peptide elutes is its retention time. This should be consistent between batches and can help confirm identity when compared to a known reference.

### Peak Symmetry
A symmetrical peak suggests a single, pure compound. Asymmetric peaks, shoulders, or split peaks indicate impurities co-eluting or structural heterogeneity.

### Baseline Impurities
Small peaks in the baseline between the main peak and solvent front represent impurities. These may include:
- Truncated synthesis fragments
- Deletion sequences
- Oxidised or reduced variants
- Residual protecting groups
- Reagent contaminants

## What Purity Percentages Mean

| Purity | Interpretation |
|---|---|
| ≥98% | Research grade; suitable for most in vitro and in vivo applications |
| 95–97% | Acceptable for many applications; some impurity burden |
| 90–94% | Lower grade; impurity effects must be considered |
| <90% | Not recommended for mechanistic research |

OmniQure provides only ≥98% HPLC-verified peptides. Our COA data is available for every product.

## What HPLC Cannot Tell You

This is critical: **HPLC purity does not confirm identity**. A chromatogram showing 99% purity tells you that 99% of UV-absorbing material in your sample co-elutes at a single retention time. It does not confirm:

- That the compound is the correct peptide sequence
- That the compound has the correct molecular weight
- That chiral centres have the correct stereochemistry
- That the compound is the correct salt form

## The Role of Mass Spectrometry

Electrospray ionisation mass spectrometry (ESI-MS) complements HPLC by confirming molecular weight. Together, HPLC and ESI-MS provide:

- **HPLC**: Purity (what percentage is my compound?)
- **ESI-MS**: Identity (is my compound the right molecular weight?)

OmniQure provides both HPLC chromatograms and ESI-MS data for all products. Researchers who require the highest confidence in compound identity should use both datasets.

## Practical Tips for Evaluating Supplier Data

1. **Request the actual chromatogram** — not just a purity number. The shape and baseline of the chromatogram reveals what a single percentage cannot.
2. **Check the mobile phase and column** — different conditions can produce different apparent purities for the same material.
3. **Look at the scale** — a Y-axis that starts at 0.01 AU reveals impurities that a scaled-up view hides.
4. **Compare retention times** — if a supplier consistently reports the same retention time for the same peptide across batches, this supports authentic manufacturing.

## Conclusion

HPLC purity data is a necessary but not sufficient quality indicator for research peptides. Combined with ESI-MS identity confirmation, it provides a robust quality verification package. Researchers should understand both the power and limitations of these analytical techniques when evaluating the material they work with.`,
    author: "OmniQure Research Team",
    tags: ["HPLC", "Purity Testing", "Quality Control", "Mass Spectrometry", "Research Methods"],
    status: "published" as const,
    publishedAt: new Date("2026-06-25T09:00:00Z"),
    seoTitle: "HPLC Purity Testing for Research Peptides Explained | OmniQure",
    seoDescription: "A researcher's guide to understanding HPLC chromatograms, purity percentages, and the complementary role of ESI-MS in peptide identity verification.",
  },
];

export async function seedBlog() {
  const existing = await db.select().from(blogPostsTable);
  if (existing.length > 0) {
    console.log(`[seed-blog] skipped: ${existing.length} blog posts already exist`);
    return;
  }

  await db.insert(blogPostsTable).values(posts);
  console.log(`[seed-blog] inserted ${posts.length} blog posts`);
}
